Alternative buffer systems in biopharmaceutical formulations and their effect on protein stability
By:
Authors
Blaž Lebar
University of Ljubljana Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Ljubljana, Slovenia
Novartis, Global Drug Development, Technical Research & Development Biologics, Drug Product Development, Formulation Development Lek Pharmaceuticals d.d., Ljubljana, Slovenia
Mitja Zidar
Novartis, Global Drug Development, Technical Research & Development Biologics, Drug Product Development, Formulation Development Lek Pharmaceuticals d.d., Ljubljana, Slovenia
Janez Mravljak
University of Ljubljana Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Ljubljana, Slovenia
Roman Šink
Novartis, Global Drug Development, Technical Research & Development Biologics, Drug Product Development, Formulation Development Lek Pharmaceuticals d.d., Ljubljana, Slovenia
Aleš Žula
Novartis, Global Drug Development, Technical Research & Development Biologics, Drug Product Development, Formulation Development Lek Pharmaceuticals d.d., Ljubljana, Slovenia
Stane Pajk
University of Ljubljana Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Ljubljana, Slovenia
Language: English
Page range: 479 - 493
Accepted on: May 2, 2024
Published on: Sep 14, 2024
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2024 Blaž Lebar, Mitja Zidar, Janez Mravljak, Roman Šink, Aleš Žula, Stane Pajk, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.